Expression of ERBB Family Members as Predictive Markers of Prostate Cancer Progression and Mortality

SIMPLE SUMMARY: Patients diagnosed with prostate cancer are usually offered a standard treatment plan based on their Gleason score, stage, and prostate-specific antigen (PSA) level. However, studies on other cancers have shown the importance of using biomarkers in addition to clinical and pathologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Clairefond, Sylvie, Ouellet, Véronique, Péant, Benjamin, Barrès, Véronique, Karakiewicz, Pierre I., Mes-Masson, Anne-Marie, Saad, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038288/
https://www.ncbi.nlm.nih.gov/pubmed/33918389
http://dx.doi.org/10.3390/cancers13071688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038288/
https://www.ncbi.nlm.nih.gov/pubmed/33918389
http://dx.doi.org/10.3390/cancers13071688

Ejemplares similares